Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Layoff history
EMPLOYEES AFFECTED PER QUARTER · HOVER FOR DETAILS
Layoff timeline
9 EVENTSPfizer Inc. has announced layoffs affecting approximately 200 employees in its biotech division due to a loss of interest in commercializing a PROTAC inhibitor. This decision comes as the company shifts its focus away from this specific project, which has led to a restructuring within the organization. The layoffs are expected to impact operations significantly, as the affected employees were integral to the development of this therapeutic approach. The company is navigating a challenging landscape in biotech, prompting these workforce reductions to realign its strategic priorities.
Pfizer Inc. announced it laid off 100 workers at the former Seagen campus in Bothell, citing gains in productivity and efficiency driven by automation and digital technology. The company said job-related decisions were made with transparency and in compliance with laws and noted it had vacated a 61,000-square-foot office building at the Bothell campus prior to the layoffs. The article places these cuts in the context of Pfizer's 2023 acquisition of Seagen and prior actions, including the 2024 layoffs of 119 former Seagen employees and the halted construction of a manufacturing plant in Everett. Pfizer employs about 1,500 people in the Seattle area and reported $63.6 billion in revenue last year, up 7% year over year.
Pfizer Inc. has announced the layoff of 56 employees as part of a restructuring of its research and development operations in San Diego. This decision follows the company's recent sale of a site for $255 million, indicating a significant shift in its operational footprint in the area. The layoffs are part of a broader strategy to optimize resources and focus on key areas of research. Pfizer's adjustments reflect ongoing changes in the pharmaceutical industry and the company's efforts to streamline its operations. The layoffs are effective immediately as the company moves forward with its plans.
Pfizer Inc. has announced that it will lay off 62 employees at its Tampa facility. This decision is part of a broader restructuring effort within the company. The layoffs are set to take effect on October 1, 2023. Pfizer has not specified the departments affected by these cuts, but the move reflects ongoing adjustments in response to market conditions. The company continues to evaluate its workforce needs as it navigates changes in the pharmaceutical landscape.
Pfizer confirmed that roughly 150 employees at its Portage factory were laid off, citing lower volumes at the site driven by reduced demand for some products manufactured there. Company officials announced the cuts on a Tuesday, describing them as a response to decreased product demand at that facility. The article notes the layoffs affected the Portage manufacturing site specifically but does not name a department or provide a specific effective date. The report presents the reduction as an immediate workforce cut rather than a planned future action.
Pfizer Inc. has announced plans to cut around 100 jobs at its Ringaskiddy plant in Ireland. This decision is part of a broader restructuring effort within the company. The layoffs are expected to impact various roles at the facility, although specific departments affected were not disclosed. Pfizer's move reflects ongoing adjustments in its operational strategy, aiming to enhance efficiency and adapt to changing market conditions. The company has not provided a specific timeline for when these layoffs will take effect.
Pfizer Inc has cut 300 jobs as part of a corporate reduction described in coverage of the company's stock. The article reports the firm eliminated 300 positions as part of its restructuring and business adjustments; no specific locations or departments for the cuts are given. The piece frames the job reductions in the context of Pfizer's broader strategic and financial positioning and investor reaction. No specific layoff date or detailed timeline is stated in the article.
Stories from here
No one has shared a story from Pfizer, Inc. yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for Pfizer, Inc.
We'll email you the moment a new layoff is reported here.